We investigated the mechanisms by which CD8 + T-cell trafficking in placenta contributes to perinatal brain injury by studying effects of maternal CD8 + T-cell depletion (DEP) in a mouse model of intrauterine inflammation (IUI). Maternal CD8 + T cells were depleted with anti-CD8 + antibodies. IUI was induced with lipopolysaccharide (LPS).
| INTRODUCTION
Preterm birth is a significant challenge in perinatal medicine, conferring an increased risk for perinatal acute and chronic neurologic morbidity and constituting up to 70% of perinatal mortality. [1] [2] [3] [4] [5] Intrauterine inflammation (IUI) is strongly associated with preterm birth, with clinical evidence of inflammation in up to 40% of preterm births. 1, 6, 7 Furthermore, exposure to IUI during prenatal development is a known risk factor for adverse neurodevelopmental outcomes in offspring, including cerebral palsy, autism spectrum disorder, and schizophrenia. [8] [9] [10] While perinatal brain injury and preterm birth are both associated with IUI, evidence suggests that the 2 processes are regulated by divergent mechanisms. 11, 12 For instance, children born at term after threatened preterm labor were more likely to have mild neurodevelopmental delay, compared with children who were born at full term without threatened preterm labor. 13 Different cytokines and chemokines may be responsible for these divergent mechanisms. 11, 12 Apart from this knowledge, however, these mechanisms are not fully understood.
Successful pregnancy is dependent on maintenance of fetomaternal tolerance, mediated by maternal immune cells in the placenta. 14 T cells comprise 5%-20% of decidual lymphocytes, and, of these, the majority are CD8 + . These decidual CD8 + T cells play cytotoxic roles but can also contribute to immune suppression through memory T cells and may serve functions not yet known. 15 On the other hand, increased infiltration of CD4 + and CD8 + T cells from maternal circulation, in response to pro-inflammatory cytokine secretion during inflammation, is implicated in chronic chorioamnionitis, although the function of the T cells is still largely unknown. In turn, acute maternal chorioamnionitis is often linked to cases of preterm birth. 16, 17 Bizargity et al 18 found that lipopolysaccharide (LPS)-induced preterm birth was not prevented in a model of T and B cell-deficient Rag1 −/− mice. In fact, T-cell deficiency worsened the preterm birth effect of LPS in this model. The effect was partially rescued by reconstituting the mice with CD4 + T cells; and regulatory T cells (Tregs) were suggested to play a role in mediating LPS-induced preterm birth. This study, however, did not examine the role of CD8 + T cells in prematurity-associated perinatal brain injury.
Our group previously reported an increase of CD8 + T-cell trafficking in placenta with exposure to IUI (LPS) and its association with perinatal brain injury. 19 Therefore, the objective of our current study was to specifically examine the role of maternal CD8 + T cells in the pathogenesis of perinatal brain injury subsequent to IUI. We hypothesized that while maternal CD8 + T-cell depletion would not have an effect on preterm birth, it would decrease perinatal brain injury in the mouse model of IUI. or 100 μL PBS vehicle via intrauterine injection between the first and second gestational sacs of the right uterine horn. A total of 92 dams were randomly assigned to 5 treatment groups: PBS, LPS, CD8 + T-cell depletion (DEP) + PBS, DEP + LPS, and non-surgical control. Preterm birth was defined as delivery of the litter before E18.5.
| MATERIALS AND METHODS

| Animal model of IUI
| CD8 + T-cell depletion and testing
The CD8 + T cell-depleted mouse model was created by intraperitoneal injection of 200 μg anti-mouse CD8α antibody (clone 53-6.72; Bio X Cell, West Lebanon, NH, USA) at E14 and E16, as used previously.
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On E17, maternal blood and placentas were collected 6 hours after LPS injection. One-tenth volume 0.1M ethylenediaminetetraacetic acid (made from EDTA, J.T. Baker #8993-01, Phillipsburg, NJ, USA) was added to blood for prevention of coagulation, followed by lym- 
| Flow cytometry
| Preweaning behavior analysis in offspring
Neuromotor tests were performed at postnatal days (PND) 5, 9, and 13 to assess the impact of maternal CD8 + T-cell depletion on neurodevelopment in offspring. Negative geotaxis and cliff aversion tests were performed as previously described. 
| Histochemistry of fetal brains
Brains were collected on E17 6 hours after surgery and fixed in 4% 
| Gene expression in placentas
Quantitative polymerase chain reactions (qPCR) were completed based on protocols described by Manangeeswaran et al 28 Placentas
were collected 6 hours after surgery and fresh frozen on dry ice, 
| Statistical analyses
Categorical data were analyzed using either chi-squared test or
Fisher's exact test. Continuous data were tested for normality, and outliers were identified using Grubb's test. Student's t-test and oneway analysis of variance (ANOVA) were used for parametric data.
Mann-Whitney U and Kruskal-Wallis tests were used for nonparametric data. Repeated measures of littermates for neurodevelopment tests were analyzed using generalized estimating equations (SPSS; IBM Analytics, Armonk, NY, USA). Gene expression data were normalized to the geometric mean of 6 reference genes and analyzed by one-way ANOVA using qBase+ software (Biogazelle, Marlborough, MA, USA). All other analyses were performed in Prism 5 (Graphpad Software, La Jolla, CA, USA).
| RESULTS
| Validation of CD8 + T-cell depletion and flow cytometry antibodies
In the presence of depleting antibodies, CD8 + antigen may become and clone 2.43 for detection by flow cytometry, to assess CD8 + Tcell depletion in peripheral blood of mice, as performed previously. 29 The frequency of CD8 + T cells in CD8 + T cell-depleted (depleted) mice was reduced by 80% compared to non-depleted control mice ( Figure 2 ).
| Maternal CD8 + T-cell depletion did not prevent inflammation-induced preterm birth
To determine whether CD8 + T cells alone contribute to preterm birth, we depleted CD8 + T cells and induced preterm delivery by intrauterine LPS administration. Our results show that maternal CD8 + T-cell depletion, despite a slight decrease, did not significantly reduce the preterm birth rate (Table 1 ).
| Maternal CD8 + T-cell depletion prevented cortical neuronal injury
While CD8 + T-cell depletion did not affect the preterm birth rate, we sought to determine whether CD8 + T cells played a role in perinatal brain injury. On E17, 6 hours after administration of intrauterine LPS, we collected fetal brain tissue from depleted and non-depleted dams.
Neurons were identified by Nissl staining, and changes in neuronal organization and number were assessed. In intrauterine LPS-exposed fetal brains, there were evidently dead neurons in the cortex with rounded cell shape and condensed nuclei. In maternal CD8-depleted fetal brains with or without LPS exposure, the morphology of neurons was similar to that of the PBS control ( Figure 3A) . Nissl counting demonstrated that there was a significant decrease of neurons in the LPS group compared to both the PBS control group (P < .001, ANOVA with Bonferroni post hoc test) and the maternal CD8 + T celldepleted LPS group (P < .05, ANOVA with Bonferroni post hoc test) ( Figure 3B ).
| Maternal CD8 + T-cell depletion prevented adverse neuromotor outcomes in offspring exposed to IUI
A total of 23 litters were tested. Similar to our previous studies, LPSexposed pups displayed slower performance on neuromotor activity compared to PBS controls on the negative geotaxis and cliff aversion tests. Maternal CD8 + T-cell depletion significantly improved neuromotor behavior (Figure 4 ).
| qPCR confirms that positive effects of CD8 + T-cell depletion on improved neurobehavioral outcomes may be due to changes in levels of inflammatory molecules
Immune arrays demonstrate that significant changes in other inflammatory molecules were observed, primarily in chemokines and receptors (36.6%) and in pro-inflammatory cytokines (37.0%). All other groups showed significance in <30.0% of changes ( Table 2 ). The confirmatory results from single-target qPCR showed a significant difference in the levels of chemokines CCL3, CXCL10, and CCL5 between placentas of depleted and non-depleted mice. With CD8 + T-cell depletion, levels of CCL3 and CXCL10 are decreased in placentas from LPS-exposed mice, whereas levels of CCL5 are increased ( Figure 5A ).
However not significant, we saw similar decreasing trends in levels of tumor necrosis factor (TNF) and interleukin (IL)-1β in placentas from LPS-exposed depleted and non-depleted mice ( Figure 5B ).
| DISCUSSION
For the first time, our study demonstrates that depletion of mater- Fisher's exact test, P > .05.
and potentially prevent long-term sequellae to the fetus. 19, 21, 29 We reported the effects of maternal N-acetyl l-cysteine dendrimer nanoparticle (DNAC) on preterm birth and perinatal brain injury in the same model of IUI. 19 The administration of DNAC significantly reduced the preterm birth rate by decreasing placental inflammation. DNAC was effective at preventing preterm labor, but also improved the performance of offspring on neurobehavioral tests. We also noticed that in our mouse model of IUI, there was an increase in the levels of CD8 + T-cell infiltration into the placenta. DNAC treatment prevented this increase in T-cell trafficking, and we hypothesized that this prevention contributed to the improvement of fetal neurodevelopment. Comprised of both cytotoxic effector and memory T cells, they effectively kill other cells by leading to the production of cytokines and other cytotoxic molecules, if the cell expresses the antigen that they are specific to. These cytokines and molecules include TNF-α, interferon-γ, IL-1β, perforin, and granzymes. 31, 32 Other groups demonstrate that CD8 + and CD4 + T cells comprise approximately 3% of leukocytes in the E8.5 decidua, but the function of decidual T cells is unknown.
A study by Erlebacher et al 14 supports the notion that there is a lack of fetal/placental specificity for decidual CD8 + T cells. This is further corroborated by the findings of Tilburgs et al 15 Our group previously showed, utilizing mathematical models, that TNF-α but not IL-1β is associated with preterm birth. 33 Our previous 
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+ /CD8 + ratios were found to be important in multiple areas of medicine and were even involved in the prognosis and treatment of human immunodeficiency virus (HIV), in particular. For HIV patients, it is known that a low CD4 + /CD8 + ratio correlates with a worse prognosis. In a study by Mussini et al, it was also noticed that patients with lower CD4 + /CD8 + ratios were more likely to experience non-acquired immune deficiency syndrome (AIDS)-defining events, including cardiovascular events, hepatic events, and acute kidney injuries. The researchers suggested that perhaps this association occurred due to persistent activation of the immune system and that the CD4 + /CD8 + ratio could act as a marker for this.
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Serrano-Villar et al 43 found similar results in their cohort study. In their patients, a low CD4 + /CD8 + ratio was associated with increased CD8 + T-cell activation, as well as other inflammatory markers. This decreased ratio-similar to levels typically found in older individuals-was also linked to immunosenescence. Patients with a lower CD4 + /CD8 + ratio were again found to be at increased risk for non-AIDS-defining events, but they hypothesized that this may have different implications depending on the initial levels of CD4 + T cells.
Those patients with lower levels of CD4 + T cells were more likely to be impacted by immunodeficiency, while the harm in individuals with higher levels of CD4 + T cells was likely caused by inflammation.
Both research teams agreed that the CD4 + /CD8 + ratio in patients with HIV could serve as an important clinical tool for prognosis and recommendations for treatments or therapies.
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On the other hand, this lowered CD4 NaN, not a number-undetectable results; Sr. No., serial number; phosphate-buffered saline (PBS) (n = 5); lipopolysaccharide (LPS) (n = 7), LPS+CD8 depletion (DEP) (n = 7), PBS+DEP (n = 5).
T A B L E 2 (Continued) pregnancy, and having normal neurodevelopmental outcomes require ongoing adjustments to the maternal immune system, favoring immune tolerance. In healthy pregnancies, the subtypes and the functional states of CD8 + effector and effector memory T cells differ between peripheral blood and placenta. 49 It is additionally possible to prevent some adverse pregnancy outcomes by reconstitution of CD4 + T cells. 18 We propose that alterations to this balance, such we demonstrate that IUI increases trafficking of CD8 + T cells to the placenta, which in turn increases perinatal brain injury, 19 and that maternal CD8 + T-cell depletion rescues this phenotype. The subtypes and functional states of these placenta trafficking CD8 + T cells will require further study.
A potential worthwhile preventative method for perinatal brain injury caused by heightened CD8 + T-cell ratios, and CD8 + T-cell infiltration into the placenta, could be through maternal immunomodulation. In this way, treatment can be performed on the mother, without needing to cross the placenta to the fetus at all, thus keeping the fetus safe from perinatal brain injury and any adverse effects of treatment.
Indeed, in a 2014 study, our group reported that administration of mesenchymal stem cells (MSC) was able to block both preterm birth F I G U R E 5 Changes in inflammatory molecules occur due to maternal CD8 + T-cell depletion. Mice were treated with lipopolysaccharide (LPS) to induce intrauterine inflammation. Placentas were collected, and quantitative polymerase chain reactions were performed. Maternal CD8 + T-cell depletion prior to LPS exposure (A) significantly decreased levels of chemokines CCL3 and CXCL10 and increased levels of CCL5.
Levels of tumor necrosis factor and interleukin-1β were decreased (B), similarly to CCL3 and CXCL10, though not significant (*P < .05, **P < .01, ***P < .001; analysis of variance; phosphate-buffered saline
and perinatal brain injury, perhaps due to a regulation of cytokines, particularly IL-10. Maternal administration of MSCs was found to increase production of IL-10, possibly inhibiting CD8 + T-cell activation and infiltration into the placenta. Although the reduction in preterm birth rate that we observed was not statistically significant, there was a reduction of approximately 20%, which may be clinically significant. More research will be needed to investigate upon this further. Additionally, as our study for the first time presents evidence for a mechanism of perinatal brain injury mediated by CD8 + T cells, we intend to perform further research into the specific subtypes of CD8 + T cells that may be involved.
We speculate that alterations of maternal CD8 + T-cell proportions, changes in their activation, suppression patterns, and trafficking between peripheral blood and fetomaternal interface-due to IUI-may be associated with perinatal brain injury and adverse neurodevelopmental outcomes in the neonate. There is an urgent clinical need for safe, effective, and timely maternal immune-modulatory therapies to prevent these adverse neonatal outcomes associated with IUI.
Clinically, accurate diagnosis of the exact timing of IUI is very challenging and at times not possible. As maternal CD8 + T-cell depletion confers protection from IUI-induced perinatal brain injury and does not have adverse fetal and neonatal effects in the absence of IUI, we suggest that it may be possible to translate CD8 + T-cell immunemodulatory treatments universally to all at-risk pregnant women in the future as a preventative measure.
| CONCLUSIONS
In conclusion, we demonstrate that maternal CD8 + T cells mediate Current findings will guide our future studies to focus on the specific mechanism of how CD8 + T cells effect neurobehavioral outcomes and the specific subtypes involved.
